Roundtable

What Do You Think Was The Single Most Consequential Event Or Result In Pharma/Biopharma In 2023?

Pharma's Almanac

Real-World Data

How Is Your Organization Currently Leveraging Real-World Data/Evidence and What Uses Do You Anticipate in the Future?

Pharma's Almanac

Industry Wisdom

What Piece of Conventional Industry Wisdom Do You Think is Misguided, Outdated, or Just Plain Wrong?

Pharma's Almanac

Roundtable: Artificial Intelligence

In what areas of pharma/biopharma are you most excited to see increased adoption of artificial intelligence (AI) and machine learning?

Pharma's Almanac

Roundtable: Patient Centricity

How is an increased focus on patient-centric concerns influencing the way that you work?

Pharma's Almanac

Allogeneic Cell Therapy Logistics

Taking a Page from the HSCT Playbook for Allogeneic Cell Therapy Advancement

Joy Aho, Ph.D.

Be The Match BioTherapies

International Markets

In what international markets do you anticipate significant developments in the near future?

Pharma's Almanac

Disruptive Technology

What do you view as the most disruptive or transformational technology or development on the horizon?

Pharma's Almanac

Cell Therapy

Achieving Better Cell Therapy Outcomes with Data-Driven Decision Making

Chris McClain

Be The Match BioTherapies

Future of the Industry

What key indicators do you look at to predict the future of this industry?

Pharma's Almanac

Sustainability

What is your plan to build a more sustainable business practice in the coming years?

Pharma's Almanac

Cell Therapy

Expanding Access to Cell Therapies with a Patient-Centric Focus

Amy L. Ronneberg

Be The Match BioTherapies

2021 Roundup: The Year of Cell and Gene Therapy

David Alvaro, Ph.D.

Pharma's Almanac

Cell Therapy

Enabling Novel Cell Therapies by Leveraging Established Blood Stem Cell Transplant Infrastructure

Chris McClain

Be The Match BioTherapies